Log In
BCIQ
Print this Print this
 

Unyvero i60 Implant and Tissue Infection cartridge

  Manage Alerts
Collapse Summary General Information
Company Curetis N.V.
DescriptionCartridge that identifies more than 90 pathogens and more than 20 resistance markers common in eight clinical indications
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect pathogens and antibiotic resistances in implant and tissue infections; Diagnose prosthetic joint infections
Regulatory Designation
PartnerHeraeus Medical GmbH

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/20/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today